Wright, J. L., Chéry, L., Holt, S., Lin, D. W., Luedeke, M., Rinckleb, A. E., . . . Stanford, J. L. (2015). ASPIRIN AND NSAID USE IN ASSOCIATION WITH MOLECULAR SUBTYPES OF PROSTATE CANCER DEFINED BY TMPRSS2: ERG FUSION STATUS. Prostate Cancer Prostatic Dis.
Citación estilo ChicagoWright, Jonathan L., Lisly Chéry, Sarah Holt, Daniel W. Lin, Manuel Luedeke, Antje E. Rinckleb, Christiane Maier, and Janet L. Stanford. "ASPIRIN AND NSAID USE IN ASSOCIATION WITH MOLECULAR SUBTYPES OF PROSTATE CANCER DEFINED BY TMPRSS2: ERG FUSION STATUS." Prostate Cancer Prostatic Dis 2015.
Cita MLAWright, Jonathan L., et al. "ASPIRIN AND NSAID USE IN ASSOCIATION WITH MOLECULAR SUBTYPES OF PROSTATE CANCER DEFINED BY TMPRSS2: ERG FUSION STATUS." Prostate Cancer Prostatic Dis 2015.